- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term effectiveness of antipsychotics
Authors
Keywords
-
Journal
PSYCHOLOGICAL MEDICINE
Volume -, Issue -, Pages 1-5
Publisher
Cambridge University Press (CUP)
Online
2021-06-08
DOI
10.1017/s0033291721001732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia
- (2021) Yash B. Joshi et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
- (2021) Mark Abie Horowitz et al. SCHIZOPHRENIA BULLETIN
- Dopamine D2 up-regulation in psychosis patients after antipsychotic drug treatment
- (2020) Ilse A. Thompson et al. CURRENT OPINION IN PSYCHIATRY
- Promising Evidence of Antipsychotic Efficacy without Dopamine D2-Receptor Binding
- (2020) Donald C. Goff NEW ENGLAND JOURNAL OF MEDICINE
- Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
- (2020) André F. Carvalho et al. Translational Psychiatry
- Mitochondrial function parameters as a tool for tailored drug treatment of an individual with psychosis: a proof of concept study
- (2020) Tamara Bar-Yosef et al. Scientific Reports
- Network Analysis Indicates That Avolition Is the Most Central Domain for the Successful Treatment of Negative Symptoms: Evidence From the Roluperidone Randomized Clinical Trial
- (2019) Gregory P Strauss et al. SCHIZOPHRENIA BULLETIN
- Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia
- (2018) Giselli Scaini et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1–12.5 Years
- (2018) Jentien M Vermeulen et al. SCHIZOPHRENIA BULLETIN
- Long-term antipsychotic treatment of schizophrenia: does it help or hurt over a 20-year period?
- (2018) Martin Harrow et al. World Psychiatry
- Understanding and misunderstanding randomized controlled trials
- (2018) Angus Deaton et al. SOCIAL SCIENCE & MEDICINE
- Psychopathology—a Precision Tool in Need of Re-sharpening
- (2018) Frauke Schultze-Lutter et al. Frontiers in Psychiatry
- Psychiatric pharmacogenomics in the age of neuroscience: promises and challenges
- (2018) Samet Kose et al. Psychiatry and Clinical Psychopharmacology
- Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia
- (2018) Kengo Oishi et al. PLoS One
- Theranostic Biomarkers for Schizophrenia
- (2017) Matea Perkovic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia
- (2017) Martin Harrow et al. PSYCHIATRY RESEARCH
- A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
- (2017) Sameer Jauhar et al. JAMA Psychiatry
- The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies
- (2015) Antonio Vita et al. BIOLOGICAL PSYCHIATRY
- Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
- (2015) Yasunori Oda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies
- (2014) Asbjørn Hróbjartsson et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Frontale Hirnvolumenminderung durch Antipsychotika?
- (2014) V. Aderhold et al. NERVENARZT
- Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
- (2014) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Haloperidol Cytotoxicity and Its Relation to Oxidative Stress
- (2013) Martina Raudenska et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies
- (2013) P. Fusar-Poli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?
- (2013) M. Harrow et al. SCHIZOPHRENIA BULLETIN
- Differential dropout and bias in randomised controlled trials: when it matters and when it may not
- (2013) M. L. Bell et al. BMJ-British Medical Journal
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study
- (2012) M. Harrow et al. PSYCHOLOGICAL MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started